Author:
Mathad Ayyapayya S,Seetharamappa J.,Kalanur Shankara S
Subject
Materials Chemistry,Physical and Theoretical Chemistry,Spectroscopy,Condensed Matter Physics,Atomic and Molecular Physics, and Optics,Electronic, Optical and Magnetic Materials
Reference79 articles.
1. Targeting the EphB4 receptor tyrosine kinase sensitizes HER2-positive breast cancer cells to Lapatinib;Ding;Cancer Lett.,2020
2. A phase II, randomized trial using the small molecule tyrosine kinase inhibitor lapatinib as a first-line treatment in patients with FISH positive advanced or metastatic breast cancer;Gomez;J. Clin. Oncol.,2005
3. Lapatinib plus capecitabine for HER2-positive advanced breast cancer;Geyer;N. Engl. J. Med.,2006
4. J.D. Moyer, E.G. Barbacci, K.K. Iwata, L. Arnold, B. Boman, A. Cnnningham, C. Diorio, J. Doty, M.J. Morin, M.P. Moyer, M. Neveu, V.A. Pollack, M. Reynolds, D. Sloan, Induction of Apoptosis and Cell Cycle Arrest by CP-358,774, an Inhibitor of, (1997) 4838–4848.
5. Epidermal growth factor receptor (EGFR) inhibitors;Ciardiello;Encycl. Cancer.,2017
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献